Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

12871 ARTÍCULOS , VIENDO DEL 1471 AL 1485

Movement disorders associated with neuronal antibodies: a data-driven approach

Sturchio A, Dwivedi AK, Gastaldi M, Grimberg MB, Businaro P, Duque KR, Vizcarra JA, Abdelghany E, Balint B, Marsili L, Espay AJ.

J Neurol. 2022 Jul;269(7):3511-3521. doi: 10.1007/s00415-021-10934-7. Epub 2022 Jan 13.

Renal Extramedullary Hematopoiesis Incidentally Detected on 18F-FDG PET/CT Imaging

Kaya G, Bozkurt MF.

Clin Nucl Med. 2022 Apr 1;47(4):e351-e352. doi: 10.1097/RLU.0000000000004014.

SEZ6L2 Antibody-Associated Cerebellar Ataxia Responsive to Sequential Immunotherapy

Mehdiyeva A, Hietaharju A, Sipilä J.

Neurol Neuroimmunol Neuroinflamm. 2022 Jan 14;9(2):e1131. doi: 10.1212/NXI.0000000000001131. Print 2022 Mar.

The second family affected with a PRDM8-related disease

Davarzani A, Shahrokhi A, Hashemi SS, Ghasemi A, Habibi Kavashkohei MR, Farboodi N, Lang AE, Ghiasi M, Rohani M, Alavi A.

Neurol Sci. 2022 Jun;43(6):3847-3855. doi: 10.1007/s10072-021-05815-w. Epub 2022 Jan 16.

The Role of High Mobility Group Box 1 (HMGB1) in Neurodegeneration: A Systematic Review

Ikram FZ, Arulsamy A, Retinasamy T, Shaikh MF.

Curr Neuropharmacol. 2022;20(11):2221-2245. doi: 10.2174/1570159X20666220114153308.

How to Detect Isolated PEX10-Related Cerebellar Ataxia?

Nava E, Hartmann B, Boxheimer L, Capone Mori A, Nuoffer JM, Sargsyan Y, Thoms S, Rosewich H, Boltshauser E.

Neuropediatrics. 2022 Jun;53(3):159-166. doi: 10.1055/s-0041-1741383. Epub 2022 Jan 17.

The Cerebellum in Niemann-Pick C1 Disease: Mouse Versus Man

Fiorenza MT, La Rosa P, Canterini S, Erickson RP.

Cerebellum. 2023 Feb;22(1):102-119. doi: 10.1007/s12311-021-01347-3. Epub 2022 Jan 18.

A Missed Case of Area Postrema Syndrome Presenting with Neuromyelitis Optica Spectrum Disorder

Khan F, Sharma N, Ud Din M, Aziz M.

Am J Case Rep. 2022 Jan 20;23:e934649. doi: 10.12659/AJCR.934649.

Bilateral Hypertrophic Olivary Degeneration as a Paraneoplastic Syndrome of a Poorly Differentiated Carcinoma of the Upper Gastrointestinal Tract: A Case Report and Literature Review

Daneshmand A, Borhani-Haghighi A, Monabati A, Karimi M, Ostovan VR.

Neurologist. 2022 Nov 1;27(6):357-360. doi: 10.1097/NRL.0000000000000414.

Therapeutic Strategies Targeting Mitochondrial Calcium Signaling: A New Hope for Neurological Diseases?

Rodríguez LR, Lapeña-Luzón T, Benetó N, Beltran-Beltran V, Pallardó FV, Gonzalez-Cabo P, Navarro JA.

Antioxidants (Basel). 2022 Jan 15;11(1):165. doi: 10.3390/antiox11010165.

Molecular Mechanisms in Pentanucleotide Repeat Diseases

Loureiro JR, Castro AF, Figueiredo AS, Silveira I.

Cells. 2022 Jan 8;11(2):205. doi: 10.3390/cells11020205.

Patient-Specific iPSCs-Based Models of Neurodegenerative Diseases: Focus on Aberrant Calcium Signaling

Grekhnev DA, Kaznacheyeva EV, Vigont VA.

Int J Mol Sci. 2022 Jan 6;23(2):624. doi: 10.3390/ijms23020624.

Achilles swelling and ataxia in an adolescent: A case report of cerebrotendinous xanthomatosis

Sahli H, Mandour JE, Boularab J, En-Nafaa I, Fenni JE, Hommadi A.

Radiol Case Rep. 2022 Jan 13;17(3):898-901. doi: 10.1016/j.radcr.2021.12.043. eCollection 2022 Mar.

Safety and efficacy of riluzole in spinocerebellar ataxia type 2 in France (ATRIL): a multicentre, randomised, double-blind, placebo-controlled trial

Coarelli G, Heinzmann A, Ewenczyk C, Fischer C, Chupin M, Monin ML, Hurmic H, Calvas F, Calvas P, Goizet C, Thobois S, Anheim M, Nguyen K, Devos D, Verny C, Ricigliano VAG, Mangin JF, Brice A, Tezenas du Montcel S, Durr A.

Lancet Neurol. 2022 Mar;21(3):225-233. doi: 10.1016/S1474-4422(21)00457-9. Epub 2022 Jan 18.

Real-Life Turning Movements Capture Subtle Longitudinal and Preataxic Changes in Cerebellar Ataxia

Thierfelder A, Seemann J, John N, Harmuth F, Giese M, Schüle R, Schöls L, Timmann D, Synofzik M, Ilg W.

Mov Disord. 2022 May;37(5):1047-1058. doi: 10.1002/mds.28930. Epub 2022 Jan 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias